2011Jilin yixueRequires access

Efficacy of β-blocker drugs in elderly patients with cardiovascular di sease

Zhang Ji-ting

Open publisher page 0 citations

Abstract

Objective To evaluate the effects and safety of atenolol,metoprolol and bisoprolol in eld erly patients with congestive heart failure.Method Sixty-two patients with CHF were randomly divided into atenolol group(n=20),metoprolol group(n=21)and bisoprolol group(n =21).Three groups were observed heart rate,blood pressure,cardiac function and ad verse reactions after treatment for 6 months,respectively.Results The range of changes of heart rates in metoprolol group was statistically less than the other two groups(P0.05); howe v er,there was no significant difference between the bisoprolol group and atenolo l group(P0.05).Conclusion Metoprolol,atenolol and bisoprolol all are beneficial for the treatment of chr onic congestive heart failure.The effect on decreasing HR of atenolol is equal to that of bisoprolol,which is much stronger than metoprolol.

About this research paper

What this paper is about

Objective To evaluate the effects and safety of atenolol,metoprolol and bisoprolol in eld erly patients with congestive heart failure.Method Sixty-two patients with CHF were randomly divided into atenolol group(n=20),metoprolol group(n=21)and bisoprolol group(n =21).Three groups were observed heart rate,blood pressure,cardiac function and ad verse reactions after treatment for 6 months,respectively.Results The range of changes of heart rates in metoprolol group was statistically less than the other two groups(P0.05); howe v er,there was no significant difference between the bisoprolol group and atenolo l group(P0.05).Conclusion Metoprolol,atenolol and bisoprolol all are beneficial for the treatment of chr onic congestive heart failure.The effect on decreasing HR of atenolol is equal to that of bisoprolol,which is much stronger than metoprolol.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To evaluate the effects and safety of atenolol,metoprolol and bisoprolol in eld erly patients with congestive heart failure.Method Sixty-two patients with CHF were randomly divided into atenolol group(n=20),metoprolol group(n=21)and bisoprolol group(n =21).Three groups were observed heart rate,blood pressure,cardiac function and ad verse reactions after treatment for 6 months,respectively.Results The range of changes of heart rates in metoprolol group was statistically less than the other two groups(P0.05); howe v er,there was no significant difference between the bisoprolol group and atenolo l group(P0.05).Conclusion Metoprolol,atenolol and bisoprolol all are beneficial for the treatment of chr onic congestive heart failure.The effect on decreasing HR of atenolol is equal to that of bisoprolol,which is much stronger than metoprolol.

Key concepts: Bisoprolol, Metoprolol, Medicine, Atenolol, Heart failure, Cardiology, Internal medicine, Heart rate

Related papers

Back to paper searchBrowse research topicsOriginal source
Efficacy of β-blocker drugs in elderly patients with cardiovascular di sease — Research Paper | ScholarLens